Form 4: Atara Biotherapeutics Executive Jill Henrich Sells Shares to Cover Tax Obligations

Jill Henrich, EVP at Atara Biotherapeutics, sold shares to cover tax obligations related to vesting restricted stock units.

Summary

• On March 4, 2024, Jill Henrich, EVP at Atara Biotherapeutics, sold 3,879 shares of common stock.
• The shares were sold at a price of $0.72 per share.
• The sale was executed to satisfy tax withholding obligations related to the vesting of previously granted restricted stock units.
• Following the transaction, Henrich directly owns 555,001 shares of Atara Biotherapeutics.
• The sale price represents the weighted average price of all shares sold by a broker on March 4, 2024 and March 5, 2024 on behalf of a group of employees of the Issuer to satisfy the payment of withholding tax liability of such employees.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to an executive stock sale for tax purposes. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

Executive stock sales are a common occurrence, often related to compensation and tax planning. Monitoring these transactions can provide insights into executive sentiment and company performance.

Stakeholder Impact

• The stock sale has a minimal impact on shareholders as it is a small percentage of the total outstanding shares.

Key Dates